Hematologic disturbs in Down Syndrome: an scoping review protocol
DOI:
https://doi.org/10.33448/rsd-v15i2.50484Keywords:
Genetic diseases, Hematology, Research protocol, Scientific methodology, Scoping review.Abstract
Introduction: Down syndrome (DS) is the most common chromosomal disorder and is associated with a broad and distinctive spectrum of hematological abnormalities throughout life, ranging from transient neonatal conditions to persistent disorders and an increased risk of hematological malignancies. Despite extensive scientific production, the available evidence is fragmented across different fields, hindering an integrated understanding of hematological manifestations in DS. Objective: To map and synthesize the available evidence on hematological abnormalities described in individuals with Down syndrome across all age groups, study designs, and healthcare settings. Methods: This scoping review will be conducted in accordance with the Joanna Briggs Institute (JBI) methodology and reported following the PRISMA-ScR guidelines. The research question will be structured using the PCC framework, considering individuals with DS, hematological alterations (erythroid, myeloid, leukocytic, platelet, immunological, bone marrow, and hematological neoplasms), and clinical, epidemiological, experimental, or genetic studies. Searches will be performed in PubMed/MEDLINE, Embase, Scopus, Web of Science, SciELO, the Cochrane Library, and LILACS, with no restrictions on publication date or language. Study selection and data extraction will be carried out independently by two reviewers, and results will be synthesized using a descriptive and narrative approach. Conclusions: This scoping review aims to provide a comprehensive overview of hematological abnormalities in Down syndrome, identify knowledge gaps, and support clinical practice, research development, and future diagnostic and therapeutic strategies.
References
Bhatnagar, N., Nizery, L., Tunstall, O., Vyas, P., & Roberts, I. (2016). Transient Abnormal Myelopoiesis and AML in Down Syndrome: An Update. Current Hematologic Malignancy Reports, 11(5), 333–341. https://doi.org/10.1007/s11899-016-0338-x
Blood Diseases & Down Syndrome | National Down Syndrome Society (NDSS). (n.d.). Retrieved January 17, 2026, from https://ndss.org/resources/blood-diseases-syndrome
Dubaj, M., Bigosiński, K., Raniewicz, M., & Mitura-Lesiuk, M. (2025). Is it leukemia? Hematological disorders in pediatric patients with Down syndrome — case report and literature review. Medical Research Journal, 10(4), 383–388. https://doi.org/10.5603/mrj.100201
Gil, A. C. (2008). Como elaborar projetos de pesquisa (4. ed). Atlas.
Grinberg, G., Sokoloff, G., Hay, B., & Lowas, S. (2025). Hematologic Variations in Children With Down Syndrome. Journal of Pediatric Hematology/Oncology, 47(7), 371. https://doi.org/10.1097/MPH.0000000000003092
Maia, A. B. F., Nobre, O. M. M., Souza, G. R. B. D., & Almeida, R. D. (2025). A relação entre a Síndrome de Down em crianças e o risco de Leucemia Aguda: Uma revisão de literatura. Brazilian Journal of Health Review, 8(5), e83334. https://doi.org/10.34119/bjhrv8n5-321
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan—A web and mobile app for systematic reviews. Systematic Reviews, 5(1), 210. https://doi.org/10.1186/s13643-016-0384-4
Peters, M. D. J., Godfrey, C. M., Khalil, H., McInerney, P., Parker, D., & Soares, C. B. (2015). Guidance for conducting systematic scoping reviews. JBI Evidence Implementation, 13(3), 141. https://doi.org/10.1097/XEB.0000000000000050
Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis, 18(10), 2119–2126. https://doi.org/10.11124/JBIES-20-00167
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research, 104, 333–339. https://doi.org/10.1016/j.jbusres.2019.07.039
Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., … Straus, S. E. (2018). PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/M18-0850
Weijerman, M. E., van Furth, A. M., Vonk Noordegraaf, A., van Wouwe, J. P., Broers, C. J. M., & Gemke, R. J. B. J. (2008). Prevalence, Neonatal Characteristics, and First-Year Mortality of Down Syndrome: A National Study. The Journal of Pediatrics, 152(1), 15–19. https://doi.org/10.1016/j.jpeds.2007.09.045
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Vivian Menezes Irineu, Henrique Pires Bramante
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
